Header links
Intranet
Donate now
image/svg+xml Map
Contact us

Rosario Pardo Diaz

Rosario Pardo Diaz

Institutions of which they are part

Research technician
Diabetes and Metabolism
Vall Hebron Institut de Recerca
Rosario Pardo Diaz

Rosario Pardo Diaz

Rosario Pardo Diaz

Institutions of which they are part

Research technician
Diabetes and Metabolism
Vall Hebron Institut de Recerca

Projects

Neuroprotección en la retinopatía diabética: una nueva estrategia terapéutica

IP: Rafael Simó Canonge
Collaborators: Rosario Pardo Diaz, Patricia Bogdanov Baruj, Laura Natalia Distefano
Funding agency: Ministerio Economía, Industria y Competitividad
Funding: 187200
Reference: SAF2012-35562
Duration: 01/01/2013 - 31/12/2015

Mecanismos moleculares de la restricción calórica en tejido adiposo blanco

IP: Josep A Villena Delgado
Collaborators: Rosario Pardo Diaz
Funding agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 75020
Reference: SAF2011-23886
Duration: 01/01/2012 - 30/06/2013

Ministerio de Ciencia

Papel del coactivador PGC-1 beta en tejido adiposo blanco y su contribución al desarrollo de la obesidad y la diabetes de tipo 2

IP: Josep A Villena Delgado
Collaborators: Rosario Pardo Diaz
Funding agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 168190
Reference: SAF2008-03644
Duration: 01/01/2009 - 31/03/2012

Ministerio de Ciencia

Related news

Dra. Andreea Ciudin

A new guideline proposes a change in the pharmacological approach to obesity

The work represents a paradigm shift in the clinical approach to this chronic, multifactorial disease, based on the clinical context of each patient and not only on weight loss.

Dra. Andreea Ciudin, Marta Comas i Juan José Cortés

A new oral drug for obesity shows positive results in an international study

The results of a phase 3 clinical trial show that orforglipron reduces body weight by an average of 11% and improves cardiovascular risk factors.

Equip del grup de Diabetis i Metabolisme del VHIR

Fundaluce supports research into a new therapeutic strategy for retinitis pigmentosa

Dr. Maria Llorián-Salvador, from the Diabetes and Metabolism Research Group at VHIR, is leading this project to identify new therapies for this inherited disease that causes progressive vision loss.

See more

Related professionals

Neda Akhlaghi

Neda Akhlaghi

Postdoctoral researcher
Liver Diseases
Read more
Rebeca Blanch Garcia

Rebeca Blanch Garcia

Research technician
Gene Therapy at Nervous System
Read more
Leidy Alejandra Gonzalez Molano

Leidy Alejandra Gonzalez Molano

Research technician
Microbiome Research
Read more
Cristian Ariel González Cabrera

Cristian Ariel González Cabrera

Postdoctoral researcher
Neurodegenerative Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.